A new nasal spray which could protect people from all Covid variants is set to start human trials.
The researchers used a supercomputer to design proteins which target ‘vulnerable sites’ on the surface of Covid-19.
They targeted the virus’ infectious machinery’ in three places rather than one, making the drug far less likely to detach than other treatments. ‘When we put the spike protein and our antiviral therapeutic in a test tube together for a week, they stayed connected and never fell apart.’The treatment reduced Covid symptoms and prevented infections, the researchers found after testing it on mice with a nasal spray.
Covid cannot infect the body without binding to the receptor, which suggests the treatment will work against new variants.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Africa must learn lessons from failure to distribute Covid-19 vaccines, report finds💉Low coronavirus vaccination rates across Africa are a result of “consequential failures” in the distribution of jabs, rather than limited access, a report has warned
続きを読む »
Hospitals Forced To Bar Relatives Amid Soaring Covid RatesHealth bosses have issued a stark warning that they expect Easter Covid pressures to be as “bad as any winter”.
続きを読む »
Boris Johnson Fined For Breaking COVID-19 Lockdown RulesU.K. Prime Minister Boris Johnson will be fined for attending rule-breaking gatherings during lockdown
続きを読む »
Queensland Covid grants were approved improperly and $96m may not be repaid, report saysQueensland Audit Office finds concessional loan scheme beset by administrative problems
続きを読む »
‘Couldn’t sleep last night’: joy at New Zealand airports as Covid travel ban on Australians liftsChange to border restrictions marks first step in welcoming international visitors back to country after two years
続きを読む »
Queensland Covid grants were approved improperly and $96m may not be repaid, report saysQueensland Audit Office finds concessional loan scheme beset by administrative problems
続きを読む »